# Clinical trials recruiting in Poland: 1,518 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,518 trials recruiting or not yet recruiting with a site in Poland, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Poland: 1,518 rows for $75.90, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 30 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/poland

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,518
- Recruiting or not yet: 1,518
- Read on: November 19, 2026

## Trials

The 25 newest of 1,518, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947264 | Effects of Low-Volume Static Stretching on Posterior Chain Flexibility in Professional Football Players | Józef Piłsudski University of Physical Education | Not applicable | Recruiting | Flexibility, Range of Motion | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947264) |
| November 18, 2026 | NCT07944859 | Impact of Advanced Parkinson Therapies on Clinical Status: Deep Brain Stimulation and Foslevodopa/Foscarbidopa | Medical University of Warsaw | Observational | Recruiting | Parkinson's Disease (PD), Malnutrition Elderly | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944859) |
| November 18, 2026 | NCT07944274 | Active Versus Vehicle Home Care During PRX S Treatment for Mild-to-Moderate Facial Acne | Medical University of Silesia | Not applicable | Not yet recruiting | Acne Vulgaris | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944274) |
| November 17, 2026 | NCT07941609 | A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLC | AstraZeneca | Phase 2 | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941609) |
| November 17, 2026 | NCT07941440 | Clinical Outcomes of PRX S With Standardized Home Care in Mild-to-Moderate Facial Acne. | Medical University of Silesia | Not applicable | Not yet recruiting | Acne Vulgaris | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07941440) |
| November 16, 2026 | NCT07939633 | Effects of Omega-3 Supplementation on Motor Performance and Bone Turnover Markers in Women: A Pilot Study | Wroclaw University of Health and Sport Sciences | Not applicable | Recruiting | Motor Performance, Bone Turnover Markers, Bone Mineral Density | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939633) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 10, 2026 | NCT07929532 | Computer-Assisted Segmentation of Craniofacial Structures and Osteotomy Planning Using CBCT and CT | Hospital of the Ministry of Interior, Kielce, Poland | Observational | Not yet recruiting | Craniofacial Structure Segmentation, Virtual Osteotomy Planning | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929532) |
| November 10, 2026 | NCT07929051 | A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With Obrixtamig | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Advanced Cancer | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929051) |
| November 10, 2026 | NCT07928245 | A Study of Brenipatide in Participants With Major Depressive Disorder | Eli Lilly and Company | Phase 2 | Not yet recruiting | Major Depressive Disorder | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928245) |
| November 9, 2026 | NCT07925658 | Autonomic and Immune Effects of Regional Anesthesia in Total Hip Arthroplasty | Poznan University of Medical Sciences | Not applicable | Not yet recruiting | Hip Ostearthritis | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925658) |
| November 9, 2026 | NCT07924709 | Functional Recovery After PENG Block Plus Periarticular Injection Versus Periarticular Injection Alone in Total Hip Arthroplasty | Poznan University of Medical Sciences | Not applicable | Not yet recruiting | Hip Ostearthritis | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924709) |
| November 9, 2026 | NCT07924670 | Intravenous Dexamethasone for PENG Block Analgesia in Children Undergoing Hip Surgery | Poznan University of Medical Sciences | Phase 4 | Not yet recruiting | Hip Surgeries, DDH | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924670) |
| November 6, 2026 | NCT07920887 | A Study of Bimagrumab in Participants With HFpEF | Eli Lilly and Company | Phase 2 | Not yet recruiting | Heart Failure, Diastolic, Diastolic Heart Failure, Heart Failure, Normal Ejection Fraction, Heart Failure, Preserved... | 540 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920887) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 5, 2026 | NCT07919236 | Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With Insulin | Medical University of Bialystok | Not applicable | Recruiting | Type 2 Diabetes | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919236) |
| November 5, 2026 | NCT07918209 | Remote Rehabilitation in Patients With HFpEF (PATRON-HF) | American Heart of Poland | Not applicable | Recruiting | Heart Failure With Preserved Ejection Fraction | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918209) |
| November 4, 2026 | NCT07917364 | Asprosin and miRNA Expression in Young Women With Metabolic Syndrome | University of Applied Sciences in Nowy Targ | Observational | Recruiting | Metabolic Syndrome, Insulin Resistance, Obesity, Abdominal, Dyslipidemias | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917364) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07910123 | Study Evaluating the Safety and Efficacy of the TMChM Prosthesis in the Treatment of People With Chronic Flexor Tendon Fingers Injuries | ChM sp. z o.o. | Not applicable | Not yet recruiting | Tendon Injuries | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910123) |
| November 2, 2026 | NCT07908914 | Comparing Radiotherapy Dose Strategies for Symptom Relief in Large Solid Tumors | Affidea Nu-med Center of Oncological DIagnostics and Therapy | Not applicable | Not yet recruiting | Solid Tumor | 426 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908914) |
| October 29, 2026 | NCT07903532 | Multicenter Study for External Validation of the TB-NET Score | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Observational | Recruiting | Tumor Burden, Neuroendocrine (NE) Tumors | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903532) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Uniwersyteckie Centrum Kliniczne | Gdansk | 74 |
| Uniwersytecki Szpital Kliniczny w Poznaniu | Poznan | 35 |
| Poznan University of Medical Sciences | Poznan | 31 |
| Medical University of Warsaw | Warsaw | 25 |
| Medical University of Silesia | Zabrze | 24 |
| Uniwersytecki Szpital Kliniczny w Bialymstoku | Bialystok | 17 |
| MTZ Clinical Research Powered by Pratia | Warsaw | 14 |
| National Institute of Cardiology | Warsaw | 12 |
| Medical Network Spółka z o.o. WIP Warsaw IBD Point Profesor Kierkuś | Warsaw | 12 |
| Wroclaw Medical University | Wroclaw | 11 |
| Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie | Lublin | 11 |
| Uniwersytecki Szpital Kliniczny w Opolu | Opole | 9 |
| Centrum Badan Klinicznych PI-House sp. z o.o. | Gdansk | 9 |
| Centrum Medyczne NeuroProtect | Warsaw | 8 |
| Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu | Wroclaw | 8 |
| Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego We Wroclawiu | Wroclaw | 8 |
| Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu | Wroclaw | 7 |
| Klinika Ambroziak Dermatologia | Warsaw | 7 |
| Institute of Psychiatry and Neurology | Warsaw | 7 |
| Uniwersytecki Szpital Kliniczny W Poznaniu | Poznan | 7 |
| Jagiellonian University Medical College | Krakow | 7 |
| Pratia S.A. | Bydgoszcz | 6 |
| University Clinical Hospital in Opole | Opole | 6 |
| Zanamed Medical Clinic Sp. z o.o. | Lublin | 6 |
| Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | Warsaw | 6 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 44 |
| Phase 1/2 | 60 |
| Phase 2 | 215 |
| Phase 2/3 | 55 |
| Phase 3 | 512 |
| Phase 4 | 42 |
| Not applicable | 344 |
| Observational | 245 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 61 |
| Heart Failure | 45 |
| Obesity | 42 |
| Neoplasms | 42 |
| Colitis, Ulcerative | 32 |
| Crohn Disease | 30 |
| Atrial Fibrillation | 28 |
| Recurrence | 28 |
| Overweight | 27 |
| Diabetes Mellitus, Type 2 | 26 |
| Breast Neoplasms | 26 |
| Multiple Myeloma | 25 |
| Coronary Artery Disease | 24 |
| Neoplasm Metastasis | 23 |
| Lung Neoplasms | 21 |
| Small Cell Lung Carcinoma | 20 |
| Prostatic Neoplasms | 20 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 19 |
| Colorectal Neoplasms | 17 |
| Ovarian Neoplasms | 16 |
| Myocardial Infarction | 15 |
| Myasthenia Gravis | 15 |
| Endometrial Neoplasms | 15 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 14 |
| Renal Insufficiency, Chronic | 14 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 72 |
| Medical University of Warsaw | 59 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 53 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 45 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 38 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 32 |
| Poznan University of Medical Sciences | 32 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 29 |
| Jagiellonian University | 28 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 26 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 25 |
| Medical University of Gdansk | 24 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 23 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 23 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 22 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 19 |
| Wroclaw Medical University | 18 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 17 |
| Medical University of Silesia | 17 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 17 |
| Poznan University of Physical Education | 16 |
| Medical University of Bialystok | 15 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 14 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 13 |
| The Jerzy Kukuczka Academy of Physical Education in Katowice | 10 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Printing companies in the United States](https://specstream.ai/data/businesses/printing-companies/united-states)
- [Thai restaurants in the United States](https://specstream.ai/data/businesses/thai-restaurants/united-states)
- [B2B advertising and marketing companies in the United States](https://specstream.ai/data/businesses/b2b-advertising-and-marketing-companies/united-states)
- [Commercial printers in the United States](https://specstream.ai/data/businesses/commercial-printers/united-states)
- [Fmcg wholesalers in the United States](https://specstream.ai/data/businesses/fmcg-wholesalers/united-states)
- [Law firms in the United States](https://specstream.ai/data/businesses/law-firms/united-states)
